CYRISMA | $7,000,000 | (Oct 10, 2024)
Truthset | $5,000,000 | (Oct 10, 2024)
Vultron | $4,850,000 | (Oct 10, 2024)
Certified by Founder
Lodge
SimBioSys, Inc.
start up
United States
- Chicago, Illinois
- 26/10/2021
- Series A
- $15,000,000
SimBioSys is a technology company on a mission to deploy Computational Oncology to transform decision making and patient experience in Cancer Care. By virtualizing cancer, clinicians and patients are empowered with a better understanding of the disease and can assess all available options computationally to truly individualize treatment.
- Industry Biotechnology Research
- Website https://www.simbiosys.com/
- LinkedIn https://www.linkedin.com/company/simbiosys-inc/
Arda Therapeutics | $43,000,000 | (Oct 10, 2024)
Braintrust(US) | $36,000,000 | (Oct 10, 2024)
Holobiome | Undisclosed Amount | (Oct 10, 2024)
MeWe | $6,000,000 | (Oct 10, 2024)
Molg | $5,500,000 | (Oct 10, 2024)
LEVY Health | $4,500,000 | (Oct 10, 2024)
Prime Security | $6,000,000 | (Oct 10, 2024)
OpenGradient | $8,500,000 | (Oct 10, 2024)
DRAWER AI | $5,000,000 | (Oct 10, 2024)
ShiraTronics, Inc. | $66,000,000 | (Oct 10, 2024)